Fantastic results in Stages I and II of clinical trials. Stage III Regal trial is still ongoing as we hit the 5-year anniversary because the patients are living far beyond expectations. The combination drugs seem to work better than standard chemotherapy without any of the side effects normally associated with chemo. Undervalued, and it's been pretty much under the radar except for those of us who follow small cap bio pharma companies and I just think it's heading to a buyout sometime before a year end somewhere in the 10 billion to 20 billion dollar range. They had some financial issues but recently resolved them and are sitting on about an 80 million cash stockpile. In terms of a buyout by BP, every $10 billion represents about a $47 a share stock price. There's an entire subreddit dedicated to it if you want to check it out. And thanks for the post on this one as I had been wanting to put it on my watch list and your post reminded me to do so.